Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

Reset
4335 results found

Changes in infection-related hospitalizations in children following pandemic restrictions: an interrupted time-series analysis of total population data

Todd, IMF; Miller, JE; Rowe, SL; Burgner, DP; Sullivan, SG

(2021), Int. J. Epidemiol., 1435-1443

DOI: 10.1093/ije/dyab101

COVID-19 in Australia: our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phase

Shaban, RZ; Li, CC; O'Sullivan, MVN; Gerrard, J; Stuart, RL; Teh, J; Gilroy, N; Sorrell, TC; White, E; Bag, S; Hackett, K; Chen, SCA; Kok, J; Dwyer, DE; Iredell, JR; Maddocks, S; Ferguson, P; Varshney, K; Carter, I; Barratt, R; Robertson, M; Baskar, SR; Friend, C; Robosa, RS; Sotomayor-Castillo, C; Nahidi, S; Macbeth, DA; Alcorn, KAD; Wattiaux, A; Moore, F; McMahon, J; Naughton, W; Korman, TM; Catton, M; Kanapathipillai, R; Romanes, F; Rowe, E; Catford, J; Kennedy, B; Qiao, M; Shaw, D

(2021), Intern. Med. J., 42-51

DOI: 10.1111/imj.15105

Viperin binds STING and enhances the type-I interferon response following dsDNA detection

Crosse, KM; Monson, EA; Dumbrepatil, AB; Smith, M; Tseng, YY; van der Hoek, KH; Revill, PA; Saker, S; Tscharke, DC; Marsh, ENG; Beard, MR; Helbig, KJ

(2021), Immunol. Cell Biol., 373-391

DOI: 10.1111/imcb.12420

Analgesic and adjuvant properties of exercise with vaccinations in healthy young population

Lee, VY; Bohn-Goldbaum, E; Fong, J; Barr, IG; Booy, R; Edwards, KM

(2021), Human Vaccines Immunother., 2058-2064

DOI: 10.1080/21645515.2020.1859322

Characterization and Application of Precore/Core-Related Antigens in Animal Models of Hepatitis B Virus Infection

Hong, XP; Luckenbaugh, L; Perlman, D; Revill, PA; Wieland, SF; Menne, S; Hu, JM

(2021), Hepatology, 99-115

DOI: 10.1002/hep.31720

Origins and Evolution of the Primate Hepatitis B Virus

Locarnini, SA; Littlejohn, M; Yuen, LKW

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.653684

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin

Netter, HJ; Barrios, MH; Littlejohn, M; Yuen, LKW

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.652962

Editorial: Origin and Evolution of Hepatitis Viruses

Osiowy, C; Yuen, L

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.740255

Autochthonous and Travel Acquired Hepatitis E Virus in Australia

O'Keefe, J; Tracy, L; Yuen, L; Bonanzinga, S; Li, X; Chong, B; Nicholson, S; Jackson, K

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.640325

Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets

Riddell, S; Goldie, S; McAuley, AJ; Kuiper, MJ; Durr, PA; Blasdell, KR; Tachedjian, M; Druce, JD; Smith, TRF; Broderick, KE; Vasan, SS

(2021), Front. Immunol.

DOI: 10.3389/fimmu.2021.694857

The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency

Khoury, G; Lee, MY; Ramarathinam, SH; McMahon, J; Purcell, AW; Sonza, S; Lewin, SR; Purcell, DFJ

(2021), Front. Genet.

DOI: 10.3389/fgene.2021.680725

The orf virus (ORFV) protein OV20.0 interacts with the microprocessor complex subunit DGCR8 to regulate miRNA biogenesis and ORFV infection

Liao, GR; Tseng, YY; Tseng, CY; Lo, CY; Hsu, WL

(2021), FEBS Lett., 2897-2908

DOI: 10.1002/1873-3468.14231

K160 in the RNA-binding domain of the orf virus virulence factor OV20.0 is critical for its functions in counteracting host antiviral defense

Liao, GR; Tseng, YY; Tseng, CY; Huang, YP; Tsai, CH; Liu, HP; Hsu, WL

(2021), FEBS Lett., 1721-1733

DOI: 10.1002/1873-3468.14099

Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort

Bailie, CR; Franklin, L; Nicholson, S; Mordant, F; Alpren, C; Stewart, T; Barnes, C; Fox, A; Druce, J; Subbarao, K; Catton, M; van Diemen, A; Sullivan, SG

(2021), Epidemiol. Infect.

DOI: 10.1017/S0950268821000315

Optimal allocation of PCR tests to minimise disease transmission through contact tracing and quarantine

Baker, CM; Chades, I; McVernon, J; Robinson, AP; Bondell, H

(2021), Epidemics

DOI: 10.1016/j.epidem.2021.100503

Development of an influenza pandemic decision support tool linking situational analytics to national response policy

Shearer, FM; Moss, R; Price, DJ; Zarebski, AE; Ballard, PG; McVernon, J; Ross, JV; McCaw, JM

(2021), Epidemics

DOI: 10.1016/j.epidem.2021.100478

Passive Sampling of SARS-CoV-2 for Wastewater Surveillance

Schang, C; Crosbie, ND; Nolan, M; Poon, R; Wang, M; Jex, A; John, N; Baker, L; Scales, P; Schmidt, J; Thorley, BR; Hill, K; Zamyadi, A; Tseng, CW; Henry, R; Kolotelo, P; Langeveld, J; Schilperoort, R; Shi, BQ; Einsiedel, S; Thomas, M; Black, J; Wilson, S; McCarthy, DT

(2021), Environ. Sci. Technol., 10432-10441

DOI: 10.1021/acs.est.1c01530

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

Fulford, TS; Van, H; Gherardin, NA; Zheng, SN; Ciula, M; Drummer, HE; Redmond, S; Tan, HX; Boo, I; Center, RJ; Li, F; Grimley, SL; Wines, BD; Nguyen, THO; Mordant, FL; Ellenberg, P; Rowntree, LC; Kedzierski, L; Cheng, AC; Doolan, DL; Matthews, G; Bond, K; Hogarth, PM; McQuilten, Z; Subbarao, K; Kedzierska, K; Juno, JA; Wheatley, AK; Kent, SJ; Williamson, DA; Purcell, DFJ; Anderson, DA; Godfrey, DI

(2021), EBioMedicine

DOI: 10.1016/j.ebiom.2021.103729

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

McMahon, JH; Zerbato, JM; Lau, JSY; Lange, JL; Roche, M; Tumpach, C; Dantanarayana, A; Rhodes, A; Chang, J; Rasmussen, TA; Mackenzie, CA; Alt, K; Hagenauer, M; Roney, J; O'Bryan, J; Carey, A; McIntyre, R; Beech, P; O'Keefe, GJ; Wichmann, CW; Scott, FE; Guo, N; Lee, ST; Liu, ZQ; Caskey, M; Nussenzweig, MC; Donnelly, PS; Egan, G; Hagemeyer, CE; Scott, AM; Lewin, SR

(2021), EBioMedicine

DOI: 10.1016/j.ebiom.2021.103252

Uptake, barriers and correlates of influenza vaccination among people who inject drugs in Australia

Price, O; Dietze, P; Sullivan, SG; Salom, C; Peacock, A

(2021), Drug Alcohol Depend.

DOI: 10.1016/j.drugalcdep.2021.108882

Sample pooling on the Cepheid Xpert (R) Xpress SARS-CoV-2 assay

Graham, M; Williams, E; Isles, N; Buadromo, E; Toatu, T; Druce, J; Catton, M; Lin, C; Howden, BP; Williamson, DA

(2021), Diagn. Microbiol. Infect. Dis.

DOI: 10.1016/j.diagmicrobio.2020.115238

A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples

Phillips, TR; Tabesh, M; Fairley, CK; Maddaford, K; Pasricha, S; Wigan, R; De Petra, V; Williamson, DA; Chow, EPF

(2021), Diagn. Microbiol. Infect. Dis.

DOI: 10.1016/j.diagmicrobio.2021.115455

Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP

Tseng, YY; Liao, GR; Lien, A; Hsu, WL

(2021), Comp. Struct. Biotechnol. J.., 1072-1080

DOI: 10.1016/j.csbj.2021.01.032

Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions

Kronbichler, A; Harrison, EM; Wagner, J

(2021), Comp. Struct. Biotechnol. J.., 415-423

DOI: 10.1016/j.csbj.2020.12.031

Oropharyngeal gonorrhoea infections among heterosexual women and heterosexual men with urogenital gonorrhoea attending a sexual health clinic in Melbourne, Australia

Allen, C; Fairley, CK; Chen, MRY; Maddaford, K; Ong, JJ; Williamson, DA; Chow, EPF

(2021), Clin. Microbiol. Infect., 1799-1804

DOI: 10.1016/j.cmi.2021.03.033

Changing Epidemiology of Respiratory Syncytial Virus in Australia-Delayed Re-Emergence in Victoria Compared to Western Australia/New South Wales (WA/NSW) After Prolonged Lock-Down for Coronavirus Disease 2019 (COVID-19)

McNab, S; Do, LAH; Clifford, V; Crawford, NW; Daley, A; Mulholland, K; Cheng, D; South, M; Waller, G; Barr, I; Wurzel, D

(2021), Clin. Infect. Dis., 2365-2366

DOI: 10.1093/cid/ciab240

Incidence of Invasive Pneumococcal Disease Higher Among People Notified With Markers of Hepatitis C Virus Infection: Population-based Surveillance in Victoria, Australia, 2001-2017

Gibney, KB; MacLachlan, J; Coutts, R; Higgins, N; Strachan, J

(2021), Clin. Infect. Dis., E319-E325

DOI: 10.1093/cid/ciaa1110

Clinical Presentation of Incident Syphilis Among Men Who Have Sex with Men Taking HIV Pre-Exposure Prophylaxis in Melbourne, Australia

Peel, J; Chow, EPF; Denham, I; Schmidt, T; Buchanan, A; Fairley, C; Williamson, DA; Bissessor, M; Chen, MY

(2021), Clin. Infect. Dis., E934-E937

DOI: 10.1093/cid/ciab052

Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features

Rowntree, LC; Chua, BY; Nicholson, S; Koutsakos, M; Hensen, L; Douros, C; Selva, K; Mordant, FL; Wong, CY; Habel, JR; Zhang, WJ; Jia, XX; Allen, L; Doolan, DL; Jackson, DC; Wheatley, AK; Kent, SJ; Amanat, F; Krammer, F; Subbarao, K; Cheng, AC; Chung, AW; Catton, M; Nguyen, THO; van de Sandt, CE; Kedzierska, K

(2021), Clin. Transl. Immunol.

DOI: 10.1002/cti2.1258

Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8(+) T cells

Nguyen, THO; McAuley, JL; Kim, Y; Zheng, MZM; Gherardin, NA; Godfrey, DI; Purcell, DFJ; Sullivan, LC; Westall, GP; Reading, PC; Kedzierska, K; Wakim, LM

(2021), Clin. Transl. Immunol.

DOI: 10.1002/cti2.1242

3 4 5 6 7 8 9 10 11